Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nutex Health Inc.NUTX · Entity 4803 | Director | June 14, 2023 | June 15, 2023 |
| Pioneer Acquisition I CorpPACH · Entity 5855 | Director · Chief Executive Officer · 10% owner | June 17, 2025 | June 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nutex Health Inc.
Report date June 14, 2023 · Filed June 15, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee note(2) | 81,746 |
Reported balance
After 2023-06-14 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-06-14 · Purchase · Acquired 50,000 · Balance 81,746 F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.4257 to $0.4301 inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4. F2: Mitchell Creem, a Director of the registrant is a co-trustee of the Creem Family Trust, the direct owner of 81,746 of the securities of the registrant reported herein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.4257 to $0.4301 inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.
F2: Mitchell Creem, a Director of the registrant is a co-trustee of the Creem Family Trust, the direct owner of 81,746 of the securities of the registrant reported herein.
Pioneer Acquisition I Corp
Report date June 17, 2025 · Filed June 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B ordinary shares, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee footnote | 6,325,000 |
Reported balance
Holding disclosure · report date 2025-06-17 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 6,325,000 F1: Includes up to 825,000 Class B ordinary shares that will be forfeited depending on the extent to which the underwriters' over-allotment option is exercised. F2: Pioneer Acquisition 1 Sponsor Holdco LLC (the "Sponsor") is the record holder of the Class B ordinary shares reported herein. Mitchell Creem is a managing member of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor and may be deemed to have or beneficial ownership of the securities held directly by the Sponsor. Mitchell Creem disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes up to 825,000 Class B ordinary shares that will be forfeited depending on the extent to which the underwriters' over-allotment option is exercised.
F2: Pioneer Acquisition 1 Sponsor Holdco LLC (the "Sponsor") is the record holder of the Class B ordinary shares reported herein. Mitchell Creem is a managing member of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor and may be deemed to have or beneficial ownership of the securities held directly by the Sponsor. Mitchell Creem disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2023 Filed Jun 15, 2023 18:18 UTC | Nutex Health Inc. NUTX · Entity 4803 | PurchaseCommon Stock | 50,000 | $0.43 | $21,415.00 |
DisclosureSEC source: 0001486189-23-000005 · primary_doc.xml · nonDerivative · entry 1 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See note(2) Disclosed balance after: 81,746 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.4257 to $0.4301 inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4. F2 · ownership.direct: Mitchell Creem, a Director of the registrant is a co-trustee of the Creem Family Trust, the direct owner of 81,746 of the securities of the registrant reported herein. Read SEC document |
| May 09, 2022 Filed May 10, 2022 18:59 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock Award | 21,208 | $3.89 | $82,499.12 |
DisclosureSEC source: 0001486189-22-000012 · primary_doc.xml · nonDerivative · entry 1 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,208 F1 · shares: Vesting 1/12 on date of grant and 1/12 on the last day of each month beginning May 2022 through March 2023. Read SEC document |
| May 09, 2022 Filed Dec 30, 2022 20:35 UTC Amendment | Nutex Health Inc. NUTX · Entity 4803 | OtherRestricted Stock | 21,208 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001486189-22-000021 · primary_doc.xml · nonDerivative · entry 2 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · date: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock. F1 · kind: The Amendment reports the rescission of the Restricted Stock Awards initially granted on May 9, 2022, as reported in the original Form 4. F2 · price: The restricted stock award was voided ab initio and the reporting person returned the restricted stock subject to the May 9, 2022 award to the issuer for no consideration and the issuer cancelled such restricted stock. Read SEC document |
| May 09, 2022 Filed Dec 30, 2022 20:35 UTC Amendment | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock | 21,208 | $3.89 | $82,499.12 |
DisclosureSEC source: 0001486189-22-000021 · primary_doc.xml · nonDerivative · entry 1 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,208 Read SEC document |
| April 01, 2022 Filed Apr 8, 2022 18:42 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantDirector Stock Option (right to buy) · Derivative | 182,000 | $2.75 Strike: $2.75 | $500,500.00 |
DisclosureSEC source: 0001486189-22-000008 · primary_doc.xml · derivative · entry 1 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,120 Underlying: Common Stock · 182,000 shares Expires 2032-04-01 Read SEC document |
| January 28, 2021 Filed Feb 3, 2021 19:41 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $1.61 Strike: $1.61 | $72,450.00 |
DisclosureSEC source: 0001486189-21-000002 · primary_doc.xml · derivative · entry 2 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,120 Underlying: Common Stock · 45,000 shares Expires 2028-01-28 F1 · derivative.exercise_date: Quarterly 25% ,fully vested upon change in control, fully vested upon closing of merger. Read SEC document |
| August 12, 2020 Filed Sep 9, 2020 13:31 UTC | Nutex Health Inc. CLNH · Entity 4803 | PurchaseCommon Stock | 31,746 | $20,000.00 | $634,920,000.00 |
DisclosureSEC source: 0001486189-20-000014 · primary_doc.xml · nonDerivative · entry 1 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,746 F1 · balance_after: Does not include 85,120 options to purchase common shares, previously reported. Read SEC document |
| May 11, 2020 Filed Jun 18, 2020 14:16 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantDirector Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000009 · primary_doc.xml · derivative · entry 1 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,120 Underlying: Common Stock · 30,000 shares Expires 2027-05-11 Read SEC document |
| January 27, 2020 Filed Apr 28, 2020 15:27 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001572821-20-000001 · primary_doc.xml · derivative · entry 1 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,120 Underlying: Common Stock · 45,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: The options vest quarterly over a one year period with vesting to occur at the first day of each new quarter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.